Ryu Juhee, Choe Nakwon, Kwon Duk-Hwa, Shin Sera, Lim Yeong-Hwan, Yoon Gwangho, Kim Ji Hye, Kim Hyung Seok, Lee In-Kyu, Ahn Youngkeun, Park Woo Jin, Kook Hyun, Kim Young-Kook
Chonnam University Research Institute of Medical Sciences, Jeollanam-do, Republic of Korea.
The BK21 FOUR Center for Glocal Future Biomedical Scientists at Chonnam National University Medical School, Jeollanam-do, Republic of Korea.
Mol Ther Nucleic Acids. 2021 Dec 22;27:645-655. doi: 10.1016/j.omtn.2021.12.031. eCollection 2022 Mar 8.
Vascular calcification (VC), or calcium deposition inside the blood vessels, is common in patients with atherosclerosis, cardiovascular disease, and chronic kidney disease. Although several treatments are available to reduce calcification, the incidence of VC continues to rise. Recently, there have been several reports describing the regulation of circular RNAs (circRNAs) in various diseases. However, the role of circRNAs in VC has not yet been fully explored. Here, we investigated the function of circSmoc1-2, one of the circRNAs generated from the gene, which is downregulated in response to VC. CircSmoc1-2 is localized primarily to the cytoplasm and is resistant to exonuclease digestion. Inhibition of circSmoc1-2 worsens VC, while overexpression of circSmoc1-2 reduces VC, suggesting that circSmoc1-2 can prevent calcification. We went on to investigate the mechanism of circSmoc1-2 as a microRNA sponge and noted that miR-874-3p, the predicted target of circSmoc1-2, promotes VC, while overexpression of circSmoc1-2 reduces VC by suppressing miR-874-3p. Additionally, we identified the potential mRNA target of miR-874-3p as Adam19. In conclusion, we revealed that the circSmoc1-2/miR-874-3p/Adam19 axis regulates VC, suggesting that circSmoc1-2 may be a novel therapeutic target in the treatment of VC.
血管钙化(VC),即血管内的钙沉积,在动脉粥样硬化、心血管疾病和慢性肾病患者中很常见。尽管有几种治疗方法可用于减少钙化,但VC的发病率仍在持续上升。最近,有几份报告描述了环状RNA(circRNA)在各种疾病中的调控作用。然而,circRNA在VC中的作用尚未得到充分探索。在此,我们研究了circSmoc1-2的功能,它是由该基因产生的circRNA之一,在VC反应中表达下调。circSmoc1-2主要定位于细胞质,并且对外切核酸酶消化具有抗性。抑制circSmoc1-2会使VC恶化,而circSmoc1-2的过表达则会减轻VC,这表明circSmoc1-2可以预防钙化。我们接着研究了circSmoc1-2作为微小RNA海绵的机制,并注意到circSmoc1-2的预测靶标miR-874-3p促进VC,而circSmoc1-2的过表达通过抑制miR-874-3p来减轻VC。此外,我们确定miR-874-3p的潜在mRNA靶标为Adam19。总之,我们揭示了circSmoc1-2/miR-874-3p/Adam19轴调节VC,这表明circSmoc1-2可能是治疗VC的一个新的治疗靶点。